期刊文献+

甘草酸二铵脂质体的制备及其性质的研究 被引量:2

Preparation and characterization of diammonium glycyrrhizinate liposomes
下载PDF
导出
摘要 目的:研究甘草酸二铵阳离子脂质体的制备方法和脂质体的性质。方法:采用均匀设计筛选最佳处方,逆相蒸发法制备甘草酸二铵脂质体;葡聚糖凝胶柱法测定其包封率;用透射电镜观察脂质体的外观形态,马尔文测定仪测定脂质体的粒径和Zeta电位;并用溶出度第3法考察了脂质体的释放规律。结果:制得脂质体的包封率约为(56±1.54)%(n=3);脂质体的形态为粒径均匀的球形或近球形,粒径为(183±9)nm(n=3),Zeta电位为(22.8±6)mV(n=3);脂质体的体外释药符合Higuchi方程;具有较好的稳定性。结论:采用逆相蒸发法,添加十八胺可制得具有较高包封率及稳定性的甘草酸二铵阳离子脂质体,制得脂质体的体外释放具有缓释特点。 Objective:To prepare and characterize diammonium glycyrrhizinate (DG) cationic liposomes. Methods:Liposomes were prepared by reverse-phase evaporation technique. The uniform design with computer-based optimization was utilized to optimize the formulation and preparation procedure of DG liposomes. The encapsulation efficiency was determined by Sephadex-G50 chromatography. The morphological examination of DG liposomes was performed using transmission electron microscopy (TEM). The particle size and Zeta potential of the liposomes were measured by Zetamaster. The release rate of DG from liposomes was tested by the third method of dissolution test under Chinese pharmacopoeia (2005 Edition, Part 11 ). Results:The liposomes with spherical or ellipsoidal shape and better stability featured the encapsulation efficiency of (56 ± 1.54)% (n = 3 ) , the mean particle size of ( 183 ± 9) nm (n = 3) , and Zeta potential of (22.8 ± 6) mV ( n = 3 ). The release kinetics in vitro obeyed Higuchi' s equation. Conclusion:By reverse-phase evaporation technique and complex of lipid membrane with octadecylamine, the encapsulation efficiency and stability of DG cationic liposomes could be increased. The liposomes featured a sustained release of DG in vitro.
作者 沈洁 栾立标
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第5期361-364,共4页 Chinese Journal of New Drugs
关键词 甘草酸二铵 阳离子脂质体 包封率 体外释放 diammonium glycyrrhizinate cationic liposome encapsulation efficiency release in vitro
  • 相关文献

参考文献5

  • 1HU YJ,LIU Y,WANG JB,et al.Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin[J].J Pharm Biomed Anal,2004,36(4):915 -919.
  • 2吴锡铭.甘草酸铵的药动学和药效学等的研究进展[J].药学通报,1987,22(8):449-453.
  • 3SZOKA F JR,PAPAHADJOPOULOS D.Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation[J].Proc Natl Acad Sci USA,1978,75(9):4194 -4198.
  • 4TROTTA M,PEIRA E,DEBERNARDI F,et al.Elastic liposomes for skin delivery of dipotassium glycyrrhizinate[J].Int J Pharm,2002,241(2):319 -327.
  • 5TROTTA M,PEIRA E,CARLOTTI ME,et al.Deformable liposomes for dermal administration of methotrexate[J].Int J Pharm,2004,270(1 -2):119 -125.

共引文献7

同被引文献21

  • 1唐晓荞,杨祥良.灯盏花素磷脂复合物改善大鼠小肠吸收的研究[J].中国中药杂志,2005,30(3):222-225. 被引量:31
  • 2苗彩云,邓树海,陈江飞.氧化苦参碱负电荷脂质体的制备及理化性质研究[J].中国药学杂志,2006,41(18):1400-1404. 被引量:6
  • 3孙考祥,王爱萍,黄丽军,梁荣才,刘珂.双氯酚酸钠脂质体的制备及其眼部药代动力学[J].药学学报,2006,41(11):1094-1098. 被引量:15
  • 4杨莉斌,胡荣.抗肿瘤药物脂质体粒径对肿瘤靶向性的影响[J].国外医学(药学分册),2007,34(3):174-176. 被引量:7
  • 5XIAO YY, SONG YM, CHEN ZP,et al. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats[ J]. Int J Pharm ,2006,307 ( 1 ) :77 - 82.
  • 6MAITI K, MUKHERJEE K, GANTAIT A,et al. Curcumin-phospholipid complex : Preparation, therapeutic evaluation and pharmacokinetic study in rats[J], lnt J Pharm,2007,330(1 -2): 155 - 163.
  • 7Zhao B,Moochhala SM,Lu J,et al.Determination of pyri-dostigmine bromide and its metabolites in biological samples[J].J Pharm Sci,2006,9(11):71.
  • 8Kluwe WM,Page JG,Toft JD,et al.Pharmacological andtoxicological evaluation of orally administered pyridostigminein dogs[J].Fundam Appl Toxicol,1990,14(1):40-53.
  • 9Hegazy N,Demirel M,Yazan Y.Preparation and in vitro e-valuation of pyridostigmine bromide microparticles[J].Int JPharm,2002,242(1-2):171-174.
  • 10Carreo-Gómez B,Duncan R.Everted rat intestinal sacs:anew model for the quantitation of P-glycoprotein mediated-ef-flux of anticancer agents[J].Anticancer Res,2000,20(5A):3157-3161.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部